Sugi Predict

Sugi Predict / Compounds / SCHEMBL2210233

SCHEMBL2210233

SCHEMBL2210233

CN(C)/C=C/C(=O)c1ccsc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 2/20 0.58
▸ MAPT P10636 7/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ LMNA P02545 4/20 0.54
▸ HPGD P15428 3/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ CYP2C19 P33261 2/20 0.54
▸ HTT P42858 2/20 0.54
▸ ALOX12 P18054 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.51
▸ POLB P06746 4/20 0.51
▸ NPC1 O15118 3/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ CES2 O00748 1/20 0.48
▸ CES1 P23141 1/20 0.48
▸ GPR52 Q9Y2T5 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2210238 1.00 RECQL (0.58) RECQLMAPTRAB9ALMNAHPGD
SCHEMBL23251385 0.78 MAPT (0.81) RECQLMAPTRAB9ALMNAHPGD
SCHEMBL14354072 0.78 GPR52 (0.58) RECQLRAB9AHPGDCYP2C19ALDH1A1
SCHEMBL14354071 0.78 GPR52 (0.58) RECQLRAB9AHPGDCYP2C19ALDH1A1
SCHEMBL23117785 0.76 GUSB (0.56) RECQLMAPTLMNAPOLBCES2
SCHEMBL3379219 0.75 CES2 (0.48) RAB9ALMNAHPGDHTTALDH1A1
SCHEMBL3379216 0.75 CES2 (0.48) RAB9ALMNAHPGDHTTALDH1A1
SCHEMBL425338 0.73 RECQL (1.00) RECQLMAPTRAB9ALMNAHPGD
SCHEMBL446006 0.73 RECQL (1.00) RECQLMAPTRAB9ALMNAHPGD
SCHEMBL29176317 0.73 RECQL (1.00) RECQLMAPTRAB9ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4273864-A — — None — — JP disclosed
EP-1924578-B1 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS LILLY CO ELI (US) 2013-11-06 — — EP disclosed
EP-1924578-B1 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS LILLY CO ELI (US) 2013-11-06 — — EP disclosed
WO-2012175513-A1 THIENYLPYRI(MI)DINYLPYRAZOLE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-12-27 — — WO disclosed
US-7981882-B2 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder ELI LILLY AND COMPANY (US) 2011-07-19 — — US disclosed
US-7981882-B2 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder ELI LILLY AND COMPANY (US) 2011-07-19 — — US disclosed
US-7981882-B2 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder ELI LILLY AND COMPANY (US) 2011-07-19 — — US disclosed
EP-1558607-B1 COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES VERTEX PHARMA (US) 2010-05-05 — — EP disclosed
US-20080214520-A1 6-N-Linked Heterocycle-Substituted 2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists ELI LILLY AND COMPANY 2008-09-04 — — US disclosed
US-20080214520-A1 6-N-Linked Heterocycle-Substituted 2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists ELI LILLY AND COMPANY 2008-09-04 — — US disclosed
EP-0486782-A1 Improved process for the synthesis of alpha-((dialkylamino)substituted-methylene)-beta-oxo-(substituted) propanenitriles AMERICAN CYANAMID COMPANY (US) 1992-05-27 — — EP disclosed
US-5103015-A 5-(substituted)isoxazole compounds AMERICAN CYANAMID COMPANY (US) 1992-04-07 — — US disclosed
US-5059709-A Reacting substituted isoxazole with dialkylamide dimethylacetal; anxiolytic agents AMERICAN CYANAMID COMPANY (US) 1991-10-22 — — US disclosed
EP-0025819-B1 SUBSTITUTED PYRAZOLO (1,5-A) PYRIMIDINES, AND THEIR PREPARATION AMERICAN CYANAMID COMPANY (US) 1983-10-12 — — EP disclosed
EP-0029103-B1 6- AND 8-HETEROARYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINES AMERICAN CYANAMID COMPANY (US) 1983-05-18 — — EP disclosed
US-4374988-A ANXIOLYTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1983-02-22 — — US disclosed
US-4281000-A Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents AMERICAN CYANAMID COMPANY (US) 1981-07-28 — — US disclosed
EP-0029103-A1 6- and 8-Heteroaryl-1,2,4-triazolo(4,3-b)pyridazines AMERICAN CYANAMID COMPANY (US) 1981-05-27 — — EP disclosed
US-4260756-A TRANQUILIZERS AMERICAN CYANAMID COMPANY (US) 1981-04-07 — — US disclosed
EP-0025819-A1 Substituted pyrazolo (1,5-a) pyrimidines, and their preparation AMERICAN CYANAMID COMPANY (US) 1981-04-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214520-A1 6-N-Linked Heterocycle-Substituted 2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists HTR2C, HTR3B, HTR1A RECQL 1201/4885MAPT 4671/4885RAB9A 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.